ライフサイエンスコーパス: beta-cryptoxanthin

1 s-lutein, all-trans-zeaxanthin and all-trans-beta-cryptoxanthin).

2 FEV(1)% after controlling for vitamin E and beta-cryptoxanthin.

3 r = 0.44 for beta-carotene, and r = 0.50 for beta-cryptoxanthin.

4 for lutein and 1.68 (95% CI: 0.99, 2.86) for beta-cryptoxanthin.

5 g beta-carotene, lutein, alpha-carotene, and beta-cryptoxanthin.

6 gest association was seen with vitamin E and beta-cryptoxanthin.

7 rotenoids beta-carotene, alpha-carotene, and beta-cryptoxanthin.

8 90 (95% CI: 0.84, 0.96; P-trend < 0.001) for beta-cryptoxanthin.

9 hydroxy xanthophylls lutein, zeaxanthin and beta-cryptoxanthin.

10 nged from 0.03 for beta-carotene to 0.40 for beta-cryptoxanthin.

11 ns ranged from 0.13 for lycopene to 0.51 for beta-cryptoxanthin.

12 mic response and the colonic availability of beta-Cryptoxanthin.

13 recursors alpha-carotene, beta-carotene, and beta-cryptoxanthin.

14 itamin C, alpha-carotene, beta-carotene, and beta-cryptoxanthin.

15 : alpha-carotene, 0.35; beta-carotene, 0.28; beta-cryptoxanthin, 0.35; lutein/zeaxanthin, 0.28; lycop

16 beta-carotene, 0.95 (95% CI: 0.70, 1.29) for beta-cryptoxanthin, 0.82 (95% CI: 0.60, 1.12) for lycope

17 6, 54.5, and 54.6 micro mol/L, respectively; beta-cryptoxanthin: 0.12, 0.16, and 0.16 micro mol/L, re

18 of lycopene (28%), lutein/zeaxanthin (17%), beta-cryptoxanthin (15%), total carotenoids (16%), serum

19 tene (5-fold), alpha-carotene (19-fold), and beta-cryptoxanthin (2-fold) concentrations; total-body v

20 carotene (1483%), alpha-carotene (145%), and beta-cryptoxanthin (67%) (P < or = 0.0001).

21 noid scores for other carotenoids, including beta-cryptoxanthin, alpha-carotene, and beta-carotene, w

22 een plasma and BMC concentrations of lutein, beta-cryptoxanthin, alpha-carotene, and beta-carotene.

23 D risk, whereas no association was found for beta-cryptoxanthin, alpha-carotene, and beta-carotene.

24 (phytoene, phytofluene, lutein, zeaxanthin, beta-cryptoxanthin, alpha-carotene, beta-carotene and ly

25 dinal association between serum carotenoids (beta-cryptoxanthin, alpha-carotene, beta-carotene, lutei

26 fold difference in beta-carotene relative to beta-cryptoxanthin and 36% of the variation and 4-fold d

27 and plasma and lipoprotein concentrations of beta-cryptoxanthin and alpha- and beta-carotene than did

28 Levels of lutein, zeaxanthin, beta-cryptoxanthin and beta-carotene in hexane extracts

29 onses were generated for lutein, zeaxanthin, beta-cryptoxanthin and beta-carotene in kaki, peach and

30 contributors to TEAC activity, while lutein, beta-cryptoxanthin and beta-carotene were primary contri

31 Other minor carotenoids were antheraxanthin, beta-cryptoxanthin and beta-carotene, while zeaxanthin w

32 eir levels were 15-fold higher than those of beta-cryptoxanthin and beta-carotene.

33 Recent epidemiological data on beta-cryptoxanthin and cardiovascular disease are lackin

34 g xanthophylls such as lutein, zeaxanthin or beta-cryptoxanthin and carotenes such as beta-carotene,

35 lower among women reporting intake values of beta-cryptoxanthin and lutein/zeaxanthin in the upper 2

36 ive oil) on the in vitro bioaccessibility of beta-Cryptoxanthin and phytosterols, a MFGM containing b

37 s between higher intake of beta-carotene and beta-cryptoxanthin and risk of hearing loss.

38 the antioxidants were modeled together, only beta-cryptoxanthin and supplemental zinc were statistica

39 ain antioxidant micronutrients, particularly beta-cryptoxanthin and supplemental zinc, and possibly d

40 -carotene, lycopene, lutein, zeaxanthin, and beta-cryptoxanthin and the risk of colon cancer.

41 amounts of mono-esterified lauric acid with beta-cryptoxanthin and with cryptocapsin.

42 Provitamin A carotenoids (beta-carotene and beta-cryptoxanthin) and capsanthin were present at highe

43 hyll concentrations (lutein + zeaxanthin and beta-cryptoxanthin) and hydrocarbon carotenoids (lycopen

44 otene, lutein plus zeaxanthin, lycopene, and beta-cryptoxanthin) and risk of HNC and HNC subtypes in

45 beta-carotene, 0.91 (95% CI: 0.46, 1.81) for beta-cryptoxanthin, and 1.35 (95% CI: 0.68, 2.69) for lu

46 ed 2 wk apart were > or = 0.89 for lycopene, beta-cryptoxanthin, and alpha- and beta-carotene.

47 as assayed for ascorbic acid, beta-carotene, beta-cryptoxanthin, and alpha- and gamma-tocopherol.

48 ns of alpha-carotene, beta-carotene, lutein, beta-cryptoxanthin, and ascorbic acid increased by more

49 ed the oxidative cleavage of alpha-carotene, beta-cryptoxanthin, and beta-apo-8'-carotenal to yield r

50 Furthermore, the BA of lutein, beta-cryptoxanthin, and beta-cryptoxanthin esters was sh

51 Higher intakes of beta-carotene, beta-cryptoxanthin, and folate, whether total or from di

52 n Americans had higher mean serum vitamin C, beta-cryptoxanthin, and lutein + zeaxanthin but lower fo

53 entrations of alpha-carotene, beta-carotene, beta-cryptoxanthin, and lutein+zeaxanthin were 0.25, 0.2

54 ncy and intakes of vitamin C, beta-carotene, beta-cryptoxanthin, and lutein-zeaxanthin from food (P <

55 intakes of vitamins C and E, beta-carotene, beta-cryptoxanthin, and lutein-zeaxanthin from food, or

56 intakes of vitamins C and E, beta-carotene, beta-cryptoxanthin, and lutein-zeaxanthin from food: 0.2

57 of lycopene, alpha-carotene, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin were similar i

58 predictors of beta-carotene, alpha-carotene, beta-cryptoxanthin, and lutein/zeaxanthin.

59 m alpha-carotene, beta-carotene, zeaxanthin, beta-cryptoxanthin, and lycopene.

60 Lycopene, beta-cryptoxanthin, and vitamin C were not associated wi

61 uding alpha-carotene, beta-carotene, lutein, beta-cryptoxanthin, and zeaxanthin, showed no associatio

62 in respiratory health and that vitamin E and beta-cryptoxanthin appear to be stronger correlates of l

63 With the exception of this activity with beta-cryptoxanthin, BCO2 cleaves specifically at the 9'-

64 In general, beta-cryptoxanthin (betaCX) had higher retention than be

65 Synergistic relationships were observed for beta-cryptoxanthin concentration after irradiation.

66 ubject to between-subject variance ratio for beta-cryptoxanthin concentration was higher (0.23; 95% C

67 significantly lower plasma ascorbic acid and beta-cryptoxanthin concentrations than did nonsmokers an

68 Year 0 sum of provitamin A carotenoids and beta-cryptoxanthin concentrations were associated with m

69 There was a trend toward lower adjusted beta-cryptoxanthin concentrations with increasing level

70 A carotenoids, alpha- and beta-carotene and beta-cryptoxanthin, constituted 51% of median total caro

71 The potential of beta-cryptoxanthin (CX)-rich foods to form vitamin A (VA

72 e beta-Cryptoxanthin, tentatively identified beta-Cryptoxanthin esters and the ratio cis-/trans-beta-

73 e, the BA of lutein, beta-cryptoxanthin, and beta-cryptoxanthin esters was shown to be superior to th

74 In all acidic media, beta-cryptoxanthin exhibited the lowest degradation rate

75 ism to tailor asymmetric carotenoids such as beta-cryptoxanthin for vitamin A production.

76 a-carotene, lycopene, lutein/zeaxanthin, and beta-cryptoxanthin, have been examined in a number of ep

77 ood levels that were 27% (lycopene) to 178% (beta-cryptoxanthin) higher than those of subjects in the

78 rotene, beta-carotene, lutein, lycopene, and beta-cryptoxanthin in 2 large cohorts.

79 ticularly beta-carotene, alpha-carotene, and beta-cryptoxanthin, in both the supplemented and unsuppl

80 vely, and serum concentrations of lutein and beta-cryptoxanthin increased across the groups in a dose

81 association with beta-carotene, lutein, and beta-cryptoxanthin intakes were inverse but not signific

82 carotenoid peaks (alpha- and beta-carotene, beta-cryptoxanthin, lutein, and lycopene) plus alpha- an

83 major carotenoids (alpha- and beta-carotene, beta-cryptoxanthin, lutein, and lycopene), retinol, and

84 o had the lowest serum vitamin B-12, folate, beta-cryptoxanthin, lutein, and zeaxanthin concentration

85 e mass fraction of alpha- and beta-carotene, beta-cryptoxanthin, lutein, lycopene and zeaxanthin in m

86 pha-carotene, beta-carotene, total carotene, beta-cryptoxanthin, lutein, lycopene, retinol, and ascor

87 lasma levels of antioxidants alpha-carotene, beta-cryptoxanthin, lutein/zeaxanthin, and lycopene were

88 carotenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein/zeaxanthin, and lycopene) in

89 ficant associations of vitamin C, vitamin E, beta-cryptoxanthin, lutein/zeaxanthin, beta-carotene, an

90 vitamins C and E, retinol, and carotenoids (beta-cryptoxanthin, lutein/zeaxanthin, beta-carotene, an

91 ed intakes of alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein/zeaxanthin, lycopene, folate,

92 85-1994, the carotenoids lutein, zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, and beta-c

93 Lutein, beta-cryptoxanthin, lycopene, alpha-carotene, retinol, a

94 ry intakes of beta-carotene, alpha-carotene, beta-cryptoxanthin, lycopene, and lutein + zeaxanthin an

95 carotenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein) and TB inciden

96 enoid intake (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein+zeaxanthin) wit

97 ds, including alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein-zeaxanthin, blo

98 , high levels of circulating alpha-carotene, beta-cryptoxanthin, lycopene, and lutein/zeaxanthin were

99 ing levels of alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein/zeaxanthin were

100 carotenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, and lutein/zeaxanthin) to

101 C, and E and alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein, and zeaxanthin fro

102 lasma carotenoids (alpha- and beta-carotene, beta-cryptoxanthin, lycopene, lutein, and zeaxanthin) we

103 etween plasma alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein/zeaxanthin, retinol

104 for six weeks provoked an increment in serum beta-Cryptoxanthin of 38.9mug/dl (CI 95%; 31.0, 46.8; p<

105 beta carotene (OR, 0.91; 95% CI, 0.86-0.96), beta cryptoxanthin (OR, 0.91; 95% CI, 0.84-0.99), lutein

106 alpha-carotene, beta-carotene, lycopene, and beta-cryptoxanthin) or vitamin A after other potential r

107 (P = 0.002), beta-carotene (P < 0.001), and beta-cryptoxanthin (P < 0.001) concentrations.

108 ne (p < 0.001), 9.1 and 8.0 microg/liter for beta-cryptoxanthin (p < 0.001), and 50.6 and 46.8 microg

109 cents had higher alpha-carotene (P < 0.001), beta-cryptoxanthin (P < 0.001), and lutein and zeaxanthi

110 ren and adolescents had significantly higher beta-cryptoxanthin (P < 0.001), lutein and zeaxanthin (P

111 ds and carotenoid esters, beta-carotene, and beta-cryptoxanthin palmitate were the most abundant in p

112 rotene (r = 0.40), beta-carotene (r = 0.28), beta-cryptoxanthin (r = 0.41), lutein (r = 0.23), and vi

113 enal were also consistently detected in BCO2-beta-cryptoxanthin reaction mixtures.

114 Auroxanthin and beta-cryptoxanthin represented around 50% of total carot

115 s-lutein, all-trans-zeaxanthin and all-trans-beta-cryptoxanthin, respectively.

116 beta-carotene, lycopene, lutein, zeaxanthin, beta-cryptoxanthin), retinol, and tocopherols (alpha-toc

117 beta-carotene, lycopene, lutein, zeaxanthin, beta-cryptoxanthin, retinol, alpha-tocopherol, gamma-toc

118 while there was an inverse association with beta-cryptoxanthin (RR = 0.59, 95% CI: 0.39, 0.90; p-tre

119 In faeces, free beta-Cryptoxanthin, tentatively identified beta-Cryptoxa

120 st categories of intake ranged from 0.80 for beta-cryptoxanthin to 0.89 for alpha-carotene and lutein

121 alpha-carotene, beta-carotene, lycopene, and beta-cryptoxanthin), vitamin A, and retinol were not ass

122 beta-carotene, lutein/zeaxanthin, lycopene, beta-cryptoxanthin, vitamin A, serum beta-carotene, and

123 A decrease of beta-cryptoxanthin was observed at higher temperatures,

124 provitamin A carotenoids, beta-carotene, and beta-cryptoxanthin were each inversely associated with a

125 one standard deviation of serum vitamin E or beta-cryptoxanthin were equivalent to the negative influ

126 As for FEV(1)%, vitamin E and beta-cryptoxanthin were most strongly related to FVC% wh

127 and dietary intakes of lutein+zeaxanthin and beta-cryptoxanthin were not associated with breast cance

128 Although the pooled RRs for quintile 5 for beta-cryptoxanthin were not significant, inverse trends

129 genated carotenoids (lutein, zeaxanthin, and beta-cryptoxanthin) were detected at electrical potentia

130 nd 7-cis isomers, cis anhydrolutein, and cis beta-cryptoxanthin) were inversely associated with 15-F(

131 ange xanthophylls (cis-violaxanthin, lutein, beta-cryptoxanthin, zeaxanthin and cis-antheraxanthin) w